Boothbay Fund Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Boothbay Fund Management's LLY Position: Q2 2026 in Review
Boothbay Fund Management increased its Eli Lilly (LLY) stake by 2.2% in Q2 2026, buying an estimated $56.2K and bringing the position to 2,584 shares worth $3.1M. The position accounts for 0.04% of the portfolio, ranked #518.
Boothbay Fund Management first reported a position in LLY in Q3 2015 and has held it in 22 quarters since. The position peaked at $14.5M in Q1 2023. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Boothbay Fund Management held 2,584 shares of Eli Lilly worth $3.1M as of Q2 2026.
- Boothbay Fund Management bought 55 Eli Lilly shares in Q2 2026, an estimated $56.2K.
- Eli Lilly made up 0.04% of Boothbay Fund Management's portfolio in Q2 2026, its #518 holding.
- Boothbay Fund Management first reported a position in Eli Lilly in Q3 2015 and has held it in 22 quarters since.
- Boothbay Fund Management's Eli Lilly position peaked at $14.5M in Q1 2023.
- 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.